We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lack of Cell Adhesion Protein Paves Way for Breast Cancer Development

By LabMedica International staff writers
Posted on 09 May 2012
A protein that is deficient in some types of breast tumors has been linked to the formation of desmosomes, complex protein structures that bind cells together into tissues and organs.

Desmosomes are molecular complexes of cell adhesion and linking proteins that attach cell surface adhesion proteins to intracellular keratin cytoskeletal filaments. More...
The cell adhesion proteins of the desmosome, desmoglein and desmocollin, are members of the cadherin family of cell adhesion molecules. They are transmembrane proteins that bridge the space between adjacent epithelial cells by way of homophilic binding of their extracellular domains to other desmosomal cadherins on the adjacent cell. Both have five extracellular domains, and have calcium-binding motifs.

A protein called Perp (TP53 apoptosis effector) had been shown previously to have a role in stratified epithelial integrity and cell-cell adhesion by promoting desmosome assembly. In the current study, investigators at Stanford University (Palo Alto, CA, USA) sought to explain why mice genetically engineered to lack the gene for Perp production suffered from severe blistering of the epidermis and oral mucosa and how this type of inflammatory response was linked to formation of breast tumors.

They reported in the April 20, 2012, online edition of the journal Breast Cancer Research that Perp protein was expressed in the mammary epithelium, where it co-localized with desmosomes. Perp loss affected mammary epithelial homeostasis by causing the accumulation of inflammatory cells around mature mammary epithelium. Reduced Perp expression was detected in many human breast cancer cell lines compared to untransformed cells, and Perp-deficiency promoted the development of mouse mammary cancer.

Senior author Dr. Laura Attardi, associate professor of radiation oncology at Stanford University, said, “Perp deficiency caused defects in desmosomal protein expression in breast epithelial cells. At the same time, there was an enhanced inflammatory response in the breast tissue, and tumors tended to develop more quickly. We also found in the lab that breast cancer cells had abnormally low levels of Perp.”

Related Links:
Stanford University



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Rapid Test Reader
DIA5000
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.